The future of IgE-mediated allergy research and treatments
In her laboratory, Cecilia Berin, Ph.D., the Bunning Professor of Food Allergy Research, studies the immune basis of allergy and tolerance to foods.
Mar 30, 2023
0
2
In her laboratory, Cecilia Berin, Ph.D., the Bunning Professor of Food Allergy Research, studies the immune basis of allergy and tolerance to foods.
Mar 30, 2023
0
2
For patients with cancer, age, cancer type, and comorbidity are associated with differential COVID-19 vaccine uptake rates, according to a study published online March 15 in Cancer.
Mar 16, 2023
0
4
The search for new therapies to treat a rare type of non-Hodgkins lymphoma has had an unexpected success—identifying a potential molecular target to treat other related forms of lymphoma as well.
Mar 14, 2023
0
2
A group of University of Pittsburgh researchers has given new meaning to "knowing your ABCs." In a new study, published in the Journal of Experimental Medicine, the team showed that a type of immune cell called age-associated ...
Mar 2, 2023
0
29
Approximately 300 million people are chronically infected with the hepatitis B virus (HBV), which can cause liver cirrhosis or cancer. Consequently, there is an urgent need for the development of HBV curative therapies. Due ...
Feb 6, 2023
0
19
B vitamins. These powerhouse nutrients help your cells function at their best, protect your brain and heart, support your immune system and can even improve your mood and energy levels.
Jan 19, 2023
0
7
Hepatitis B virus (HBV) infections remain a major global health problem—according to the World Health Organization there are around 300 million HBV carriers worldwide. Current treatments rarely succeed in curing the infection.
Jan 10, 2023
0
10
Patient-reported outcomes from individuals diagnosed with relapsed or refractory large B-cell lymphoma revealed that those who received axicabtagene ciloleucel (axi-cel) immunotherapy experienced higher quality of life than ...
Jan 4, 2023
0
10
People suffering from blood cancer often have a weak immune system, putting them at higher risk of falling seriously ill with COVID-19. Some cancer therapies, moreover, result in these patients forming few or no antibodies ...
Dec 22, 2022
3
21
A single-tube eight-color multiparametric flow cytometry (MFC) panel has good sensitivity for minimal/measurable residual disease (MRD) and excellent prediction for survival among patients with B-cell acute lymphoblastic ...
Dec 21, 2022
0
0